| Ruth L Selvidge, MD | |
|
1441 Constitution Blvd, Salinas, CA 93906-3100 | |
| (831) 647-7611 | |
| Not Available |
| Full Name | Ruth L Selvidge |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 1441 Constitution Blvd, Salinas, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063422491 | NPI | - | NPPES |
| 00G794520 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G79452 (California) | Primary |
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
People facing mental health challenges are significantly more likely to have heart disease or stroke, according to a study presented today at the Canadian Cardiovascular Congress.
Scientists have tricked bone marrow into releasing extra adult stem cells into the bloodstream, a technique that they hope could one day be used to repair heart damage or mend a broken bone, in a new study published today in the journal Cell Stem Cell.
Protalex, Inc., a clinical stage biopharmaceutical company focused on the development of a class of drugs designed to treat autoimmune and inflammatory diseases including rheumatoid arthritis (RA), today announced results from its recently completed Phase 1b randomized, multiple-dose, dose-escalation study.
On two separate occasions this year, Brookdale Hospital Medical Center-;a once-venerable institution that serves some of the city's most impoverished patients-;has been threatened with expulsion from public-health insurance programs after flunking multiple government safety inspections. The hospital relies heavily on Medicaid and Medicare for financial support.
A combination of two types of blood pressure-lowering drugs, an angiotensin-converting enzyme inhibitor (ACEI) plus an angiotensin-receptor blocker (ARB), added to enzyme replacement therapy (ERT) with agalsidase-beta (Fabrazyme, Genzyme Corporation, Cambridge, MA) is the first treatment shown to stop progressive loss of kidney function in patients with severe kidney involvement due to the rare genetic disorder Fabry disease, reports a study in the September Journal of the American Society of Nephrology.
› Verified 9 days ago
| Entity Name | Sutter Bay Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013950807 PECOS PAC ID: 4284538778 Enrollment ID: O20031125000909 |
News Archive
People facing mental health challenges are significantly more likely to have heart disease or stroke, according to a study presented today at the Canadian Cardiovascular Congress.
Scientists have tricked bone marrow into releasing extra adult stem cells into the bloodstream, a technique that they hope could one day be used to repair heart damage or mend a broken bone, in a new study published today in the journal Cell Stem Cell.
Protalex, Inc., a clinical stage biopharmaceutical company focused on the development of a class of drugs designed to treat autoimmune and inflammatory diseases including rheumatoid arthritis (RA), today announced results from its recently completed Phase 1b randomized, multiple-dose, dose-escalation study.
On two separate occasions this year, Brookdale Hospital Medical Center-;a once-venerable institution that serves some of the city's most impoverished patients-;has been threatened with expulsion from public-health insurance programs after flunking multiple government safety inspections. The hospital relies heavily on Medicaid and Medicare for financial support.
A combination of two types of blood pressure-lowering drugs, an angiotensin-converting enzyme inhibitor (ACEI) plus an angiotensin-receptor blocker (ARB), added to enzyme replacement therapy (ERT) with agalsidase-beta (Fabrazyme, Genzyme Corporation, Cambridge, MA) is the first treatment shown to stop progressive loss of kidney function in patients with severe kidney involvement due to the rare genetic disorder Fabry disease, reports a study in the September Journal of the American Society of Nephrology.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ruth L Selvidge, MD 2100 Powell St, Suite 900, Emeryville, CA 94608-1826 Ph: (510) 350-2600 | Ruth L Selvidge, MD 1441 Constitution Blvd, Salinas, CA 93906-3100 Ph: (831) 647-7611 |
News Archive
People facing mental health challenges are significantly more likely to have heart disease or stroke, according to a study presented today at the Canadian Cardiovascular Congress.
Scientists have tricked bone marrow into releasing extra adult stem cells into the bloodstream, a technique that they hope could one day be used to repair heart damage or mend a broken bone, in a new study published today in the journal Cell Stem Cell.
Protalex, Inc., a clinical stage biopharmaceutical company focused on the development of a class of drugs designed to treat autoimmune and inflammatory diseases including rheumatoid arthritis (RA), today announced results from its recently completed Phase 1b randomized, multiple-dose, dose-escalation study.
On two separate occasions this year, Brookdale Hospital Medical Center-;a once-venerable institution that serves some of the city's most impoverished patients-;has been threatened with expulsion from public-health insurance programs after flunking multiple government safety inspections. The hospital relies heavily on Medicaid and Medicare for financial support.
A combination of two types of blood pressure-lowering drugs, an angiotensin-converting enzyme inhibitor (ACEI) plus an angiotensin-receptor blocker (ARB), added to enzyme replacement therapy (ERT) with agalsidase-beta (Fabrazyme, Genzyme Corporation, Cambridge, MA) is the first treatment shown to stop progressive loss of kidney function in patients with severe kidney involvement due to the rare genetic disorder Fabry disease, reports a study in the September Journal of the American Society of Nephrology.
› Verified 9 days ago
Dr. Erica Locke, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 E Romie Ln, Salinas, CA 93901 Phone: 831-759-1840 | |
Rakesh Singh, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 450 E Romie Ln, Salinas, CA 93901 Phone: 831-759-1840 Fax: 831-753-6286 | |
Lorena Monarrez, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1441 Constitution Blvd, Salinas, CA 93906 Phone: 831-755-6268 | |
Dr. Stephen Gregory Meigher, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 E Romie Ln, Salinas, CA 93901 Phone: 831-757-4333 | |
Catherine Dixon Ferguson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 E Romie Ln, Salinas, CA 93901 Phone: 831-757-4333 | |
Michael Gene Moeller, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1441 Constition Blvd, Salinas, CA 93906 Phone: 831-796-1603 |